Literature DB >> 24360957

FOXO3 selectively amplifies enhancer activity to establish target gene regulation.

Astrid Eijkelenboom1, Michal Mokry2, Lydia M Smits1, Edward E Nieuwenhuis2, Boudewijn M T Burgering3.   

Abstract

Forkhead box O (FOXO) transcription factors regulate diverse cellular processes, affecting tumorigenesis, metabolism, stem cell maintenance, and lifespan. We show that FOXO3 transcription regulation mainly proceeds through the most active subset of enhancers. In addition to the general distinction between "open" and "closed" chromatin, we show that the level of activity marks (H3K27ac, RNAPII, enhancer RNAs) of these open chromatin regions prior to FOXO3 activation largely determines FOXO3 DNA binding. Consequently, FOXO3 amplifies the levels of these activity marks and their absolute rather than relative changes associate best with FOXO3 target gene regulation. The importance of preexisting chromatin state in directing FOXO3 gene regulation, as shown here, provides a mechanism whereby FOXO3 can regulate cell-specific homeostasis. Genetic variation is reported to affect these chromatin signatures in a quantitative manner, and, in agreement, we observe a correlation between cancer-associated genetic variations and the amplitude of FOXO3 enhancer binding.
Copyright © 2013 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24360957     DOI: 10.1016/j.celrep.2013.11.031

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  30 in total

1.  Loss of KMT2D induces prostate cancer ROS-mediated DNA damage by suppressing the enhancer activity and DNA binding of antioxidant transcription factor FOXO3.

Authors:  Shidong Lv; Haoran Wen; Xiongwei Shan; Jianhua Li; Yaobin Wu; Xinpei Yu; Wenhua Huang; Qiang Wei
Journal:  Epigenetics       Date:  2019-06-28       Impact factor: 4.528

2.  Restraining FOXO3-dependent transcriptional BMF activation underpins tumour growth and metastasis of E-cadherin-negative breast cancer.

Authors:  M Hornsveld; M Tenhagen; R A van de Ven; A M M Smits; M H van Triest; M van Amersfoort; D E A Kloet; T B Dansen; B M Burgering; P W B Derksen
Journal:  Cell Death Differ       Date:  2016-04-01       Impact factor: 15.828

Review 3.  The Aging Epigenome.

Authors:  Lauren N Booth; Anne Brunet
Journal:  Mol Cell       Date:  2016-06-02       Impact factor: 17.970

4.  Foxo3 Transcription Factor Drives Pathogenic T Helper 1 Differentiation by Inducing the Expression of Eomes.

Authors:  Caroline Stienne; Michaël F Michieletto; Mehdi Benamar; Nadège Carrié; Isabelle Bernard; Xuan-Hung Nguyen; Yannick Lippi; Fanny Duguet; Roland S Liblau; Stephen M Hedrick; Abdelhadi Saoudi; Anne S Dejean
Journal:  Immunity       Date:  2016-10-11       Impact factor: 31.745

Review 5.  Transcription factors FOXO in the regulation of homeostatic hematopoiesis.

Authors:  Vijay Menon; Saghi Ghaffari
Journal:  Curr Opin Hematol       Date:  2018-07       Impact factor: 3.284

6.  FOXO3 Transcription Factor Is Essential for Protecting Hematopoietic Stem and Progenitor Cells from Oxidative DNA Damage.

Authors:  Carolina L Bigarella; Jianfeng Li; Pauline Rimmelé; Raymond Liang; Robert W Sobol; Saghi Ghaffari
Journal:  J Biol Chem       Date:  2016-12-19       Impact factor: 5.157

Review 7.  Advances in understanding the mechanisms of erythropoiesis in homeostasis and disease.

Authors:  Raymond Liang; Saghi Ghaffari
Journal:  Br J Haematol       Date:  2016-07-21       Impact factor: 6.998

8.  FOXO3 and related transcription factors in development, aging, and exceptional longevity.

Authors:  Arnold J Kahn
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2014-04-18       Impact factor: 6.053

9.  The distal upstream region of insulin-like growth factor-binding protein-1 enhances its expression in endometrial stromal cells during decidualization.

Authors:  Isao Tamura; Kosuke Jozaki; Shun Sato; Yuichiro Shirafuta; Masahiro Shinagawa; Ryo Maekawa; Toshiaki Taketani; Hiromi Asada; Hiroshi Tamura; Norihiro Sugino
Journal:  J Biol Chem       Date:  2018-02-16       Impact factor: 5.157

Review 10.  Enhancer reprogramming in tumor progression: a new route towards cancer cell plasticity.

Authors:  Luca Fagnocchi; Vittoria Poli; Alessio Zippo
Journal:  Cell Mol Life Sci       Date:  2018-04-24       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.